Page last updated: 2024-10-25

deferoxamine and Neuronal Ceroid-Lipofuscinoses

deferoxamine has been researched along with Neuronal Ceroid-Lipofuscinoses in 1 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Neuronal Ceroid-Lipofuscinoses: A group of severe neurodegenerative diseases characterized by intracellular accumulation of autofluorescent wax-like lipid materials (CEROID; LIPOFUSCIN) in neurons. There are several subtypes based on mutations of the various genes, time of disease onset, and severity of the neurological defects such as progressive DEMENTIA; SEIZURES; and visual failure.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Westermarck, T1
Santavuori, P1

Other Studies

1 other study available for deferoxamine and Neuronal Ceroid-Lipofuscinoses

ArticleYear
Principles of antioxidant therapy in neuronal ceroid lipofuscinosis.
    Medical biology, 1984, Volume: 62, Issue:2

    Topics: Antioxidants; Deferoxamine; Extracellular Space; Glutathione Peroxidase; Humans; Neuronal Ceroid-Lip

1984